businesspress24.com - Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended J
 

Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2017

ID: 1514898

(firmenpresse) - LAVAL, QUEBEC -- (Marketwired) -- 07/25/17 -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ: NEPT)(TSX: NEPT), announces that it will be holding a conference call on August 15, 2017 at 8:00 AM (EST) to discuss its first quarter results for the three months period ended June 30, 2017.

The first quarter results press release will be issued on August 14, 2017 after market close.

A replay of the call will be available for replay two hours after the call''s completion, until September 15, 2017. The telephone numbers to access the replay of the call are 1 (416) 621-4642 or 1 (800) 585-8367 (toll-free), Conference ID 54107289. The archive of the webcast, along with its accompanying presentation, will also be made available immediately in the Investors section of Neptune''s website under Investor Events and Presentations.

About Neptune Technologies & Bioressources Inc.

Neptune is a nutrition products company focused on the business of customized unique nutrition solutions, specialty ingredients and consumer brands. The company develops turnkey solutions available in various unique delivery forms. Neptune also offers premium krill oil manufactured in its state-of-the art facility and a variety of other specialty ingredients such as marine and seed oils. Neptune sells its premium krill oil under the OCEANO3® brand directly to consumers in Canada and the United States through web sales at . OCEANO3 is also sold as a turnkey solution to distributors. The Company''s head office is located in Laval, Quebec.

Neptune is also pursuing opportunities in the prescription drug markets, through its approximately 34% owned subsidiary Acasti Pharma Inc. ("Acasti"). Acasti focuses on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment of severe hypertriglyceridemia.



Contacts:
Neptune Wellness Solutions




Mario Paradis
VP & CFO, Neptune

450-687-2262 x236

Investor Relations Contact (Canada)
Pierre Boucher
MaisonBrison
1.514.731.0000


Investor Relations Contact (U.S.)
James Carbonara
Hayden IR
1.646.755.4712

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Kane Biotech Announces Removal of All Debt from its Balance Sheet and Grant of Options
Helix BioPharma Corp. Initiates Enrollment in the Third Dosing Cohort of U.S. Combination Treatment Study of Its Lung Cancer Drug Candidate L-DOS47
Bereitgestellt von Benutzer: Marketwired
Datum: 25.07.2017 - 08:30 Uhr
Sprache: Deutsch
News-ID 1514898
Anzahl Zeichen: 3120

contact information:
Contact person:
Town:

LAVAL, QUEBEC


Phone:

Kategorie:

Alternative


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 375 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2017
"
steht unter der journalistisch-redaktionellen Verantwortung von

Neptune Technologies & Bioressources Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Neptune Technologies & Bioressources Inc.



 

Who is online

All members: 10 563
Register today: 2
Register yesterday: 2
Members online: 0
Guests online: 76


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.